As manufacturing pipelines scale in line with increased demand for advanced therapies, there is further demand for digital solutions to support complex manufacturing process development.
In considering some of the top challenges facing cell and gene therapies manufacturers today, there are many opportunities for reducing the costs associated with manufacturing, while accelerating delivery timelines, all through improving processes and integrating digital solutions.
Through the content in this eBook, we will explore the impact the burgeoning era of Pharma 4.0 may have on the cell and gene therapy industry, while considering several options for digital disruption, including cloud-based and software as a service (SaaS) offerings.
This eBook features exclusive insights from key opinion leaders in the digitization space, including Martin Sternitzke, Kortney Gunther (both Senior Product Managers) and Dr. Judith Koliwer (Principal Consultant for Cell & Gene Therapy) from Körber Business Area Pharma, as well as Joe Maguire (Head of GMP Automation and Data) and Kawa Chiu, (Former Vice President of CMC, Supply Chain and GMP Systems) from Lyell Immunopharma.
In this eBook, you will find:
-
Infographic: Today’s Top Challenges for Cell and Gene Therapy Manufacturing
-
Case Study: Scaling Out Production with a Robust Digital Foundation
-
Interview: Overcoming Challenges in Cell and Gene Therapy Manufacture with Digitization, Cloud and SaaS Solutions